Dexmedetomidine may be renoprotective by reducing ischemia-reperfusion injury, according to the investigators. Dexmedetomidine may reduce the odds of delayed graft function following ...

Please provide your email address to receive an email when new articles are posted on . At 7 and 42 days postpartum, women who received dexmedetomidine had lower positive postpartum depression rates.

For the study, researchers randomly assigned patients to receive dexmedetomidine, a sedative, or a saline placebo infusion during surgery and for two hours while in recovery. They assessed patients ...

BXCL501 is an oral thin film formulation of dexmedetomidine, a selective alpha-2a receptor agonist. The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to BXCL501 ...